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Cancer-associated fibroblasts (CAFs) provide critical
metabolites for tumor growth and undergometabolic
reprogramming to support glycolysis. However, the
molecular mechanisms responsible for this change
remain unclear. Here, we report that TGF-b1- or
PDGF-induced CAFs switch from oxidative phos-
phorylation to aerobic glycolysis. We identify down-
regulation of isocitrate dehydrogenase 3a (IDH3a)
as a marker for this switch. Furthermore, miR-424
downregulates IDH3a during CAF formation. Down-
regulation of IDH3a decreases the effective level
of a-ketoglutarate (a-KG) by reducing the ratio of
a-KG to fumarate and succinate, resulting in PHD2
inhibition and HIF-1a protein stabilization. The accu-
mulation of HIF-1a, in turn, promotes glycolysis by
increasing the uptake of glucose, upregulating ex-
pression of glycolytic enzymes under normoxic con-
ditions, and inhibiting oxidative phosphorylation by
upregulating NDUFA4L2. CAFs from tumor samples
exhibit low levels of IDH3a, and overexpression of
IDH3a prevents transformation of fibroblasts into
CAFs. Our studies reveal IDH3a to be a critical meta-
bolic switch in CAFs.INTRODUCTION
The development and progression of tumors are controlled
not only by tumor cells but also by their surrounding stromal
cells (Carmeliet and Jain, 2000; Rønnov-Jessen et al., 1996;
Tlsty, 2001). Cancer-associated fibroblasts (CAFs) are activated
fibroblasts that form a large component of tumor stromal cells
(Coussens and Werb, 2002; Kalluri, 2003; Rønnov-Jessen
et al., 1995). Through specific communications with cancer cells,
CAFs directly promote tumor initiation (Bhowmick et al., 2004;CeOlumi et al., 1999), progression (Dimanche-Boitrel et al., 1994;
Orimo et al., 2005), and metastasis (Grum-Schwensen et al.,
2005; Olaso et al., 1997). CAFs produce ECM-degrading en-
zymes and secrete growth factors and cytokines, which collec-
tively promote tumor development and progression (Boire
et al., 2005; Ding et al., 2010).
Increasing evidence suggests that CAFs also can secrete me-
tabolites to fuel the growth of tumor cells. Previous studies have
shown that CAFs secrete large amounts of lactate and ketone
bodies, utilized by tumor cells for anabolic metabolism or oxida-
tive phosphorylation (Fiaschi et al., 2012). In addition, b-hydrox-
ybutyrate, one of the ketone bodies, increased cancer cell prolif-
eration approximately 3-fold compared to the control group, and
lactate promoted angiogenesis in tumor model (Bonuccelli et al.,
2010a; Fiaschi et al., 2012). However, it remains unclear why
CAFs are prone to glycolysis and which mechanism(s) controls
this metabolic reprogramming. We previously found that CAF
can be induced in vitro from fibroblasts (Li et al., 2013), which
provides a unique system to investigate the factors that drive
the metabolic transformation of fibroblasts to CAFs.
Here, we report that a reduction in the expression of the a
subunit of the isocitrate dehydrogenase 3 complex (IDH3a) is
associated with the metabolic switch from oxidative phosphory-
lation to glycolysis, and that overexpression of IDH3a prevents
fibroblasts from transforming into CAFs. A decrease in IDH3a
reduces the ratio of a-ketoglutarate (a-KG) to succinate and fu-
murate, resulting in a stabilization of HIF-1a, which, in turn, pro-
motes glycolysis in CAFs. Our results identified IDH3a as the key
molecular switch for glycolysis, and they provide an insight into
the initiation of the Warburg effect in CAFs, a critical stromal
component in tumorigenesis.RESULTS
CAFs Are Prone to Glycolysis and Enhance Tumor Cell
Growth
We and others showed previously that TGF-b and PDGF can
promote the formation of CAFs from fibroblasts. For example,ll Reports 10, 1335–1348, March 3, 2015 ª2015 The Authors 1335
PDGF can efficiently induce the conversion of fibroblasts to
CAFs, evidenced by the expression of FSP1, a specific marker
of CAFs (Figure S1A). TGF-b treatment in fibroblasts provides
similar effect (data not shown). When melanoma A375 cells
were co-cultured (1:1) with control fibroblasts or CAFs (TGF-b
induced), CAFs induced a greater increase in A375 cell prolifer-
ation than did control fibroblasts (Figure S1B). However, pre-
treatment with the glycolysis inhibitor 2-deoxyglucose (2-DG)
significantly compromised this growth-promoting effect. Inter-
estingly, CAFs had an increased uptake of 2-DG compared to
control fibroblasts, suggesting that CAFs have a higher capacity
for glucose uptake than do fibroblasts (Figure S1C).
To extend this observation in vivo, we mixed A375 cells with
control fibroblasts or with PDGF-induced CAFs, and injected
them, respectively, into the abdominal or forelimb armpit of
nude mice; this injection protocol eliminates variation among
mice to ensure comparable results in different groups. As ex-
pected, PDGF-induced CAFs did not form tumors in vivo, and
co-injection with fibroblasts did not increase tumor growth (Fig-
ure S1D). However, CAFs greatly enhanced the growth of tumor
cells in vivo. When A375 cells mixed with isolated primary CAFs
(from colon cancer), or with TGF-b-induced CAFs, were injected
using the same protocol above, we found that A375 cells mixed
with primary CAFs or TGF-b-induced CAFs grew faster than
A375 cells mixed with fibroblasts (Figure 1A). Tumors obtained
from the isolated primary CAF group showed no significant dif-
ferences compared to the tumors from the TGF-b-induced
CAF group in tumor size. These data demonstrated that the
induced CAFs function similarly to the isolated primary CAFs,
and both can promote tumor growth in vitro and in vivo.
To investigate the tumor-promoting effect of CAF, we isolated
primary fibroblasts from foreskin and treated them with TGF-b1
or PDGF-BB (Li et al., 2013). We observed that the color of the
culture medium turned from pink to orange and pH dropped
from 7.8 to 7.1 (Figure 1B). To exclude the possibility that the
lower pH was a result of rapid cell growth, we quantified cell pro-
liferation using BrdU and found that the cell proliferation ratio
(treated versus non-treated) decreased rather than increased
(Figure 1B, right) in TGF-b- or PDGF-treated fibroblasts. These
results suggested that induced CAFs produce elevated levels
of acidic catabolites compared to fibroblasts.
To determine whether these observations were due to a meta-
bolic switch from oxidative phosphorylation to glycolysis in
CAFs, we measured the glucose uptake, lactate production,
and oxygen consumption in control fibroblasts and TGF-b- or
PDGF-induced CAFs. Lactate measurements, obtained at three
time intervals (1, 2, and 3 hr), showed lactate production was
increased 2.5-fold in both TGF-b- and PDGF-induced CAFs
compared to the control fibroblasts (Figure 1C). Glucose uptake
also increased approximately 2-fold in both types of induced
CAFs compared to control fibroblasts (Figure 1D). Interestingly,
basal oxygen consumption decreased in both types of induced
CAFs to approximately 50% of the level of control fibroblasts
(p < 0.001) (Figure 1E). Moreover, the mitochondrial function of
oxidative phosphorylation in the induced CAFs also was im-
paired, as reflected by the decrease in oxygen consumption
(approximately 55 to 25 pmol/min) and by the decrease of respi-
ratory capacity (approximately 80 to 40 pmol/min). These obser-1336 Cell Reports 10, 1335–1348, March 3, 2015 ª2015 The Authorsvations suggest that glucose metabolism has switched from
oxidative phosphorylation to glycolysis in both forms of induced
CAFs.
CAFs Have Reduced IDH3a Expression
To explore the mechanism underlying this metabolic reprogram-
ming, we performed unbiased gene expression profiling of
induced CAFs by deep sequencing (GSE61797). Genes that
regulate cell metabolism (upregulated or downregulated for
more than 2-fold) in CAFs were selected (Figure 2A; Table S1).
The two induced CAFs showed similar gene expression
changes, suggesting that metabolic reprogramming is a com-
mon feature of CAFs. Of the several downregulated enzymes
involved in the TCA cycle, isocitrate dehydrogenase (IDH)1 and
IDH3a were of particular interest as both were downregulated
in the induced CAFs. To extend these observations, we per-
formed western blot analysis and found that the protein level of
IDH3a decreased dramatically 2 days after TGF-b treatment
(Figure 2B). However, no significant IDH1 downregulation was
observed (data not shown). The downregulation of IDH3a corre-
lated with the gain of FSP1 expression, suggesting that the
decreased IDH3a expression promotes the transition of fibro-
blasts to CAFs. A time-course experiment revealed that the
IDH3a protein levels started to drop at 12 hr of TGF-b (8 ng/ml)
treatment and reached a maximum in 4 days (Figure 2C, left).
The downregulation of IDH3a was the result of decreased
IDH3a mRNA as examined by real-time PCR (Figure 2C, right).
In line with this idea, no change of IDH3a was found in cells after
treatment with MG132 or chloroquine (proteasome or lysosome
inhibitors, respectively) in TGF-b-treated or untreated fibroblasts
(Figure 2D). These data suggest that IDH3a downregulation
occurred mainly through transcriptional regulation.
To confirm that IDH3a also is downregulated in the CAFs of
human colon cancer and melanoma, we performed immunoflu-
orescence and immunohistochemistry staining and found that
IDH3a expression was indeed decreased in CAFs in both colon
cancer and melanoma, compared with fibroblasts in normal
tissue (Figures 2E and S2A). In addition, CAFs isolated from fresh
human colon cancer were characterized with positive expres-
sion of F-actin and FSP-1, and exhibited a tumor-promoting
effect in vivo (Figure S2B). The CAFs isolated from tumors sam-
ples displayed an increased expression of glycolysis-related
enzymes, such as hexokinase 2 (HK2) and 6-phosphofructoki-
nase-liver type (PFKL) (Figure 2F). In addition, caveolin (CAV1),
a potential onco-protein (Sotgia et al., 2009, 2012), was downre-
gulated in these CAFs. These data demonstrated that the CAFs
isolated from clinical samples function similarly to the induced
CAFs, display reduced IDH3a expression, and promote tumor
growth in vivo.
To determine whether IDH3a downregulation switches oxida-
tive phosphorylation to glycolysis in CAFs, we generated primary
fibroblasts with IDH3a either knocked down or overexpressed.
We found that IDH3a knockdown increased glucose uptake
and lactate production (Figure 2G). In addition, IDH3a knock-
down reduced oxygen consumption in fibroblasts (Figure 2I).
Other small hairpin RNA (shRNA) targeting IDH3a showed similar
results (data not shown). In contrast, IDH3a overexpression not
only reduced the basal level of lactate production but also
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Figure 1. Cell Metabolism Switches to Glycolysis during CAF Formation
(A) Tumor growth-promoting effects of isolated CAFs and induced CAFs as shown in the growth curve plot (*p < 0.01; #p < 0.01); the image to the right displays
representative tumors.
(B) The pH value changes during CAF formation. (Left) Color of culture mediumwith or without TGF-b1/PDGF treatment. The first two plots display pH values with
or without the indicated treatments (*p < 0.05). The last two plots show the relative proliferation ratio (proliferation value in induced CAFs divided by the pro-
liferation value in control fibroblast) with indicated treatments.
(C) Lactate production in induced CAF cells, with the concentration measured by colorimetric method at the indicated time points (1, 2, and 3 hr) (*p < 0.001).
(D) Glucose uptake in fibroblasts or TGF-b-induced CAFs with or without treatment of [3H] labeled 2-DG.
(E) Basal oxygen consumption, oxidative phosphorylation (with oligomycin treatment), and maximum respiration capacity (with FCCP treatment) of fibroblasts.
Bar plots show the basal oxygen consumption (mean ± SD) of fibroblasts with or without stimulation (*p < 0.001).
Cell Reports 10, 1335–1348, March 3, 2015 ª2015 The Authors 1337
IDH3α
β-actin
Ctrl IDH3α KD
H
Time points (hours)
 1 2 3
0
20
30 control
IDH3α KD
La
ct
at
e 
pr
od
uc
tio
n
(n
m
ol
 p
er
 1
0
6
 c
el
ls
)
10
*
0
200
400
600 Control
IDH3α-KD
Glu
co
se
 up
tak
e 
F
0 8
0
200
400
600
800
1000 Control
IDH3α-OE
TGF-β 1 (ng)
Gl
uc
os
e 
up
ta
ke
 *
1 2
0
2
4
6
8
10
Control
TGF-β1
IDH3α OE
TGF-β1+IDH3α OE
Time(hours)
La
ct
at
e 
pr
od
uc
tio
n
(n
m
ol
 p
er
 m
ill
io
n 
ce
lls
)
*
E
G
Normal
colon
Colon
cancer
IDH3α FSP1 Merged with DAPI
Co
ntro
l
IDH
3α 
OE
Time (minutes)
0 40 80 120
O
C
R
 (p
m
ol
/m
in
)
200
100
300
0
Control
IDH3α KD
Basal
Oligomycin
FCCP
Retenone
OC
R 
(p
mo
l/m
in)
50
150
100
200
0
0 40 80 120
Con+TGF-β 1
IDH3α-OE+TGF-β 1
IDH3α-OE
Control
Basal FCCP
Oligomycin Retenone
Time (minutes)
1 10 19
0
50
100
150
Ctrl
IDH3α KD
Time (minutes)
O
C
R 
(p
M
ol
es
/m
in
)
* * *
O
C
R
 (p
M
ol
es
/m
in
) *
0
50
100
#
I
J
DMSO
CQ -    -    +   -    -    +
 -    +    -    -    +    -
-    -    -   +    +    +TGF-β1
IDH3α
β-actin
IDH3α
β-actin
DMSO
MG132 -    -    +     -     -    +
 -    +    -     -     +    -
-    -    -     +    +    +TGF-β1
F-actin & DAPI
CAF
B
C
A
IDH3α
β-actin
0    2     4     6    8    12TGF-β1 (ng)
FSP1
hFb hFb+TGF-β
IDH1   2.1
IDH3A 2.5
...... 12 24 48 96
0
50
100
150 Control
TGF-β 1
Time points (hrs)
Re
lat
ive
 ex
pr
es
sio
n (
%
)
12 24 48 96
0.0
0.5
1.0
1.5 Control
TGF-β 1
Time (hours)
ID
H3
A 
m
RN
A 
lev
el
****
hFb hFb+PDGF
D
β-actin
IDH3α
TGF-β1
Time (H)
-  +   -  +   -  +   -   +
12      24     48     96
HK2            2.0
PFKL          2.3
NDUFA4L2 2.1
......
IDH3α
β-actin
TG
F-β TG
F-β
 +
IDH
3α 
OE
Control
TGF-β1
IDH3α OE
IDH3α OE+TGF-β1
HK2 PFKL CAV1
0
1
2
3
4 Control
CAF
mR
NA
 re
lat
ive
 le
ve
l *
*
*
Con CAF
0.0
0.2
0.4
0.6
0.8
1.0 IDH3α
mR
NA
 re
lat
ive
 le
ve
l
FSP-1
CAFCon
β-actin
IDH3α
HK2
PFKL
CAV1
*
*
Figure 2. Downregulation of IDH3a Promotes Glycolysis in Fibroblasts
(A) Heat map of gene expression in normal fibroblasts and TGF-b-induced CAFs. A list of the predominant genes involved in glucose metabolism that are up- or
downregulated is presented.
(B) Western blot analysis of IDH3a expression in fibroblasts treated with indicated concentrations of TGF-b1.
(legend continued on next page)
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inhibited TGF-b-induced lactate production in fibroblasts (Fig-
ure 2H, left). IDH3a overexpression also reduced the basal
level of and TGF-b-stimulated glucose uptake (Figure 2H, right).
While TGF-b treatment suppressed oxygen consumption in
fibroblasts, IDH3a overexpression increased basal oxygen con-
sumption and partially restored TGF-b-mediated downregula-
tion of oxygen consumption (Figure 2J). Taken together, these
data demonstrate that IDH3a downregulation is critical for
switching energy metabolism from oxidative phosphorylation
to glycolysis in CAFs.
miR-424 Regulates IDH3a Expression
To determine the mechanism of IDH3a downregulation in TGF-
b-induced CAFs, we utilized Starbase, a web-based software,
to predict microRNAs (miRNAs) targeting the IDH3a 30UTR. We
also analyzed miRNA expression in CAFs by deep sequencing.
Both approaches lead to the identification of miR-181a and
miR-424 for targeting IDH3a (Figure 3A). However, only miR-
424 reduced firefly luciferase in the IDH3a 30UTR luciferase re-
porter assay. When the four nucleotides (Figure 3B, indicated
in red) in the IDH3a 30UTR that were predicted to associate
with miR-424 were mutated, miR-424 lost the ability to inhibit
firefly luciferase expression. These data suggest that miR-424
is involved in IDH3a downregulation. Moreover, the miR-424
level was increased in fibroblasts after 12 hr of TGF-b treatment
(Figure 3A, bottom), indicating that miR-424 mediates the TGF-
b-induced IDH3a downregulation.
To confirm that miR-424 regulates IDH3a expression, specific
oligomers targeting miR-424 were transfected into fibroblasts.
Knockdown of miR-424 increased the level of IDH3a (Figure 3C),
whereas miR-424 overexpression reduced the IDH3a in fibro-
blasts (Figure 3C, middle). Moreover, miR-424 knockdown pre-
vented the TGF-b-induced IDH3a downregulation (Figure 3C,
right). These data indicate that miR-424 inhibits IDH3a expres-
sion and is responsible for TGF-b-induced IDH3a downregula-
tion in CAFs.
To determine whether miR-424 regulates glycolysis in fibro-
blasts, we analyzed glycolysis-related enzymes by quantitative
PCR in miR-424-overexpressing fibroblasts. miR-424 overex-
pression increased the expression of glycolysis-related en-
zymes, including GLUT1, HK2, and PFKM. In contrast, expres-
sion of IDH3a decreased the expression of these enzymes
(Figure 3D, top left). Rescue expression of IDH3a also blocked
the miR-424-induced upregulation of these molecules. We also
investigated lactate production, glucose uptake, and oxygen
consumption in fibroblasts overexpressing miR-424. Lactate(C) IDH3a expression at the indicated time points after TGF-b1 stimulation. The m
plot presents the quantitative mRNA level of IDH3a (*p < 0.01).
(D) Analysis of IDH3a protein stability after MG132 and chloroquine treatments.
(E) IDH3a is downregulated in colon CAFs. Paraffin-embedded colon cancer sam
(F) Expression of IDH3a (western blot) and glycolysis-related genes (mRNA anal
(G) Analysis of lactate production and glucose uptake in fibroblasts depleted of
(H) Analysis of lactate production and glucose uptake in fibroblasts overexpressin
(I) Basal oxygen consumption, oxidative phosphorylation, and maximum respirat
basal level of oxygen consumption (*p < 0.01).
(J) Basal oxygen consumption, oxidative phosphorylation, and maximum respirat
the basal level of oxygen consumption (*p < 0.01; #p < 0.05).
Ceproduction was upregulated in miR-424-overexpressing fibro-
blasts by approximately 2-fold compared to control fibroblasts
(Figure 3D, top right). Glucose uptake, as measured by 3H-
labeled deoxyglucose, was increased more than 2-fold in
miR-424-overexpressing fibroblasts compared to control fibro-
blasts (Figure 3D, bottom left). Overexpressing miR-424 also
decreased oxygen consumption in these fibroblasts (Figure 3D,
bottom right). Furthermore, oxidative phosphorylation, as re-
flected by themaximum respiration capacity, decreased in fibro-
blasts overexpressing miR-424. Together, these data indicate
that miR-424 promotes glycolysis in CAFs by downregulating
IDH3a.
Downregulation of IDH3a Inhibits Proline Hydroxylase
Activity
Proline hydroxylase (PHD), a member of the dioxygenase family,
hydroxylated HIF-1a at prolines 402 and 564. This hydroxylation
led to the binding of E3 ligase VHL and consequent ubiquitination
and degradation of HIF-1a (Figure 4A). The activity of PHD re-
quires oxygen and a-KG, but succinate and fumurate, structural
metabolic analogs of a-KG, can inhibit this activity. Because
IDH3a converts isocitrate into a-KG, we speculated that down-
regulation of IDH3a in CAFs reduces PHD activity through
changing the ratio of a-KG to succinate/fumurate (the effective
a-KG) (Figure 4A). To test this idea, we measured the cellular
content of these metabolites by gas chromatography-mass
spectrometry (GC-MS). The level of both succinate and fumurate
increased about four times in CAFs and fibroblasts with IDH3a
knockdown. Unexpectedly, the level of a-KG also was in-
creased, although the magnitude of this increase was signifi-
cantly lower than that of succinate and fumurate (Figure 4B).
As a result, the ratio of a-KG to succinate and fumurate was
greatly reduced in CAFs and fibroblasts with IDH3a knockdown.
Because a-KG also is derived from glutamate, we examined the
expression of enzymes converting glutamate to a-KG, including
glutamic pyruvate transaminase (ALT) and aspartate amino-
transferase (AST), by quantitative PCR and western blot analysis
in CAFs. We found that the expression of ALT2 was significantly
increased in induced CAFs (Figure 4C), suggesting that the slight
elevation of a-KG is likely through the glutamate pathway by
feedback upregulation of ALT2 in CAFs and fibroblasts with
IDH3a knockdown.
To examine whether IDH3a affects PHD activity, we employed
ODD (oxygen-dependent degradation domain) luciferase assay
to measure the PHD activity in fibroblasts with IDH3a knock-
down; cells treated with cobalt chloride to mimic hypoxia wereiddle plot shows densitometry analysis of the IDH3a protein level and the right
ples were co-stained with IDH3a and FSP1 antibodies.
ysis) in CAF cells isolated from colon cancer samples (*p < 0.01).
IDH3a. Lactate production was measured at indicated time points (*p < 0.01).
g IDH3a. Lactate production was measured at indicated time points (*p < 0.01).
ion capacity of fibroblasts after IDH3a knockdown. The histogram displays the
ion capacity of fibroblasts with IDH3a overexpression. The histogram displays
ll Reports 10, 1335–1348, March 3, 2015 ª2015 The Authors 1339
control miR-424 OE
0
2
4
6
Re
lat
ive
 m
iR
-42
4 l
ev
el
Con miR-424 Over-Exp
IDH3α
GAPDH
A
β-actin
IDH3α
Co
n
miR
-42
4 s
iRN
A
Co
n
miR
-42
4 s
iRN
A
48h24h
3’ aaguuuuguACUUAACGACGAc 5’
5’ uccuuuguuUAAGCUGCUGCUu 3’
hsa-miR-424
IDH3α
B
0 12 24 48 96
0
1
2
3
4 Control
TGF-β 1
Time course (hours)
m
iR
-4
24
 le
ve
l
C
Co
n
miR
-42
4 s
iRN
A
Co
n+T
GF
-β1
miR
-42
4 s
iRN
A
+TG
F-β
1
β-actin
IDH3α
1 2 3
0
2
4
6
8
10 Control
miR-424 OE
Time points (hours)
La
ct
at
e 
pr
od
uc
tio
n
(n
m
o
l p
e
r 
1
0
6  c
e
lls
)
0
200
400
600
800
1000 Control
miR-424 OE
Gl
uc
os
e u
pt
ak
e
D
Control
miR-424 OE
Basal
Oligomycin
FCCP
Retenone
*
0
2
4
6
8
10
Re
lat
ive
 lu
cif
er
as
e 
ac
tiv
ity IDH3α-3’UTR
3’UTR(wt) + miR-424
3’UTR(mt)
3’UTR(mt) + miR-424
3’UTR(wt) + pGIPZ
0
2
4
6
8
10
Re
lat
ive
 lu
cif
er
as
e 
ac
tiv
ity
*
Vector
miR-181a
miR-424
Control miR-424
Figure 3. miR-424 Regulates the Expres-
sion of IDH3a
(A) Potential miRNAs regulating IDH3a expression.
The blue oval lists the upregulated miRNAs
determined by deep sequencing and the green
oval lists the miRNAs predicted to regulate IDH3a
(http://starbase.sysu.edu.cn; Yang et al., 2011).
The histogram shows the level of miR-424 after
TGF-b treatment.
(B) miR-424, but not miR-181a, regulates IDH3a
expression. (Top) Luciferase activity for IDH3a 30
UTR. (Bottom) Luciferase activity in wild-type or
mutant IDH3a 30 UTR groups (*p < 0.01). The nu-
cleotides indicated in red for the IDH3a seed
sequence were mutated to complementary nu-
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(C) miR-424 mediates TGF-b-induced IDH3a
downregulation. The IDH3a protein level in fibro-
blasts with miR-424 knockdown or overex-
pression, and in TGF-b1-treated fibroblastswith or
without miR-424 depletion.
(D) Effects of miR-424 overexpression on aerobic
glycolysis. The mRNA level of Glut1, HK2, and
PFKM in the fibroblasts overexpressing miR-424
or IDH3a (top left). The rate of lactate production
(top right) and glucose uptake (bottom) analyzed in
fibroblasts overexpressing miR-424. Bottom dia-
gram shows the effect of miR-424 overexpression
on basal oxygen consumption, oxidative phos-
phorylation, and maximum respiration capacity.used as a positive control. We found that IDH3a downregulation
as well as CoCl2 treatment increases ODD luciferase activity
(Figure 4D), suggesting that IDH3a knockdown suppresses
PHD activity. In addition, when we examined fibroblasts treated
with a-KG along with increasing concentrations of succinate,
a-KG decreased ODD luciferase activity, as expected. However,
succinate restored ODD activity in a dose-dependent manner
(Figure 4E), suggesting that succinate can compromise the ac-
tivity of PHD, and that the ratio of a-KG/succinate is critical in
determining this activity in vivo. To extend this contention, we
measured the tri-methylation of histone H3K4 (H3K4me3), a sub-
strate of the Jumonji family of histone demethylases (JMHD,
another member of the dioxygenase family) in CAFs and fibro-
blasts with IDH3a knockdown. We found methylation of H3K41340 Cell Reports 10, 1335–1348, March 3, 2015 ª2015 The Authorsincreased in CAFs and fibroblasts with
IDH3a knockdown (Figure S3A). In addi-
tion, fibroblasts treated with increasing
concentrations of a-KG had dose-depen-
dent decreases in H3K4 methylation
(Figure S3B). However, the addition of
succinate rescued the downregulation
of H3K4 methylation mediated by a-KG
(Figure S3C). Taken together, these data
suggest that IDH3a regulates PHD activ-
ity by reducing the ratio of a-KG to succi-
nate/fumurate.
BecauseHIF-1a is directly regulated by
PHD through PHD-mediated hydroxyl-
ation, we further examined the activity of
PHD and measured hydroxylation of HIF-1a (proline 564) in vivo.
We found that IDH3a knockdown as well as CoCl2 treatment
reduces the HIF-1a hydroxylation (Figure 4F). In contrast, the
overexpression of IDH3a increases HIF-1a hydroxylation. To
determine which isoform of PHD (PHD1, PHD2, or PHD3) was
responsible for HIF-1a hydroxylation, we knocked down three
individual PHD isoforms in fibroblasts and found that PHD2,
but not PHD1 or PHD3, significantly reduced HIF-1a hydroxyl-
ation (Figure 4G). In addition, knockdown of IDH3a also signifi-
cantly inhibited HIF-1a hydroxylation. These results indicate
that PHD2 is the predominant enzyme responsible for HIF-1a
hydroxylation, and that downregulation of IDH3a is a major fac-
tor contributing to the suppression of HIF-1a hydroxylation in
CAFs.
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Figure 4. Downregulation of IDH3a Inhibits
PHD Activity
(A) Potential mechanism bywhich IDH3a regulates
HIF-1a stability.
(B) Total content of a-KG, succinate, and fumurate
were analyzed by GC-MS. The histograms display
the relative content of a-KG, succinate, and fu-
murate in CAFs or fibroblasts depleted of IDH3a
(*p < 0.01).
(C) Enzymes involved in glutamate conversion into
a-KG were screened by quantitative PCR (bar
plot). The increase of ALT2 expression was further
validated by dose-response experiment in fibro-
blasts treated with TGF-b or PDGF.
(D) ODD luciferase activity was measured in fi-
broblasts depleted of IDH3a or treated with
100 mM CoCl2.
(E) ODD luciferase activity was measured in fi-
broblasts treated with 100 mM a-KG or succinate,
or mixtures of a-KG (100 mM) with various con-
centrations of succinate (100, 200, 300, or 400 mM,
respectively); the values were normalized to
control.
(F) Effect of IDH3a on hydroxylation of HIF-1a. The
hydroxylation level of HIF-1a was detected in fi-
broblasts depleted of or overexpressing IDH3a,
using antibody against hydroxylated HIF-1a at
proline 564. Fibroblasts were treated with 5 mg
MG132 for 6 hr before analysis.
(G) PHD2, but not PHD1 or PHD3, regulates HIF-
1a stability.IDH3a Downregulation Promotes Glycolysis by
Increasing HIF-1a Stability
As HIF-1a and c-Myc are known transcription factors in regu-
lating glycolysis, we hypothesized that these factors may
mediate the IDH3a-induced glycolytic response in CAFs. To
examine this idea, we investigated the expression of c-Myc
and HIF-1a. We found decreased expression of c-Myc, rather
than an increased one, in CAFs (Figure 5A). However, expressionCell Reports 10, 1335–134of HIF-1a was increased in CAFs, with no
significant changes for HIF-2a or HIF-3a
(Figure 5A). The HIF-1a mRNA levels in
CAFs and control fibroblast were not
significantly different (Figure 5B), sup-
porting the concept that HIF-1a accumu-
lation in CAFs is likely due to increased
protein stability rather than enhanced
transcription. Consistently, IDH3a knock-
down increased HIF-1a, whereas IDH3a
overexpression reduced HIF-1a, with
HIF-1a mRNA levels unaffected by both
treatments (Figure 5C).
To determine whether HIF-1a is
responsible for IDH3a-mediated glycol-
ysis, we treated fibroblasts with the HIF-
1a inhibitor YC-1. IDH3a knockdown
increased the expression of HK2 and
Glut1 and promoted lactate generation;
however, YC-1 treatment attenuatedthese increases (Figure 5C, bottom). In addition, miR-424 over-
expression increased, whereas miR-424 knockdown decreased
HIF-1a protein, but not mRNA (Figure 5D). Overexpression of
miR-424 also increased the expression of Glut1 and HK2 and
promoted lactate generation; however, YC-1 inhibited Glut1
and HK2 expression and abrogated the miR-424 overexpres-
sion-induced lactate production (Figure 5D, bottom). These
data support the contention that HIF-1a is responsible for the8, March 3, 2015 ª2015 The Authors 1341
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Figure 5. Downregulation of IDH3a Promotes Glycolysis by Increasing HIF-1a Stability
(A) Expression of HIF-1a, but not HIF-2a, HIF-3a, or c-Myc, increases in CAF cells.
(B) Stabilization of HIF-1a protein in induced CAF cells. Western blot shows increased protein level of HIF-1a, whereas mRNA expression is not changed.
(C) IDH3a regulates HIF-1a stabilization. (Top) Western blot shows the protein level of HIF-1a after overexpression or knockdown of IDH3a; mRNA level after
IDH3a knockdown. (Bottom) Western blot shows expression of glycolysis-related proteins in fibroblasts treated with the HIF-1a inhibitor YC-1 or depleted of
IDH3a; lactate production in fibroblasts with IDH3a knockdown and YC-1 treatment.
(D) miR-424 affects HIF-1a protein stabilization. (Top) Western blot (left) and quantitative PCR (right) of HIF-1a was performed in fibroblasts with miR-424
knockdown or overexpression. (Bottom) Western blot shows expression of proteins involved in glycolysis in fibroblasts with YC-1 treatment and/or miR-424
overexpression; lactate production in fibroblasts with miR-424 overexpression and YC-1 treatment.
(E) HIF-1a activator CoCl2 restores IDH3a-inhibited glycolysis. Western blot shows the effect of CoCl2 on the expression of genes involved in glycolysis; his-
togram shows the effects of CoCl2 on lactate production in fibroblasts with IDH3a knockdown or IDH3a overexpression.changes in glycolysis mediated by IDH3a downregulation or
miR-424 upregulation. In line with this observation, CoCl2
increased the expression of HK2 andGlut1 (as detected bywest-
ern blot) and promoted lactate production in fibroblasts. How-
ever, neither IDH3a overexpression nor miR-424 knockdown
blocked the HIF-1a-mediated increase of HK2/Glut1 expression
and lactate production (Figure 5E, right).
IDH3a Downregulation Inhibits Oxidative
Phosphorylation by Upregulating NDUFA4L2
We have shown that IDH3a knockdown or miR-424 overex-
pression increases glycolysis and reduces oxygen consumption.
Gene expression profiling also indicated that NDUFA4L2 (NADH1342 Cell Reports 10, 1335–1348, March 3, 2015 ª2015 The Authorsdehydrogenase [ubiquinone] 1 alpha subcomplex, 4-like 2), a
negative regulator of mitochondrial complex 1, was upregulated
in CAFs (Figure 2A). A previous study showed that HIF-1a upre-
gulates NDUFA4L2 expression during hypoxia in mouse embry-
onic fibroblasts (MEFs) and tumor cells (Tello et al., 2011). To
determine whether IDH3a regulates oxidative phosphorylation
through NDUFA4L2, genes that are involved in oxidative phos-
phorylation and are upregulated or downregulated in expression
profiling analysis (>2-fold), were further verified individually by
quantitative PCR. NDUFA4L2 was dramatically upregulated
(>4-fold) in fibroblasts upon IDH3a knockdown; the increase of
NDUFA4L2 in fibroblasts exhibited a dose- and time-dependent
response to TGF-b treatment (Figure 6A, bottom). However, the
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Figure 6. Downregulation of IDH3a Inhibits Oxidative Phosphorylation by Upregulating NDUFA4L2 Expression
(A) (Top) Expression of NDUFA4L2, but not PGC1a or TFB1M, is upregulated in CAFs. (Bottom) Western blot displays an increase of NDUFA4L2 in the time-
course and dose-response experiments.
(B) Downregulation of IDH3a increases expression of NDUFA4L2. mRNA analysis (plot) shows expression of NDUFA4L2 after knockdown of IDH3a or YC-1
treatment. Western blot displays protein level of NDUFA4L2 after overexpression or knockdown of IDH3a and/or YC-1 treatment.
(C) miR-424 upregulates the mRNA level and protein level of NDUFA4L2.
(D) IDH3a regulates the OCR through NDUFA4L2. Plot on the left displays the basal level of oxygen consumption (*p < 0.01). Diagram on the right shows basal
oxygen consumption, oxidative phosphorylation, and maximum respiration capacity of fibroblasts with IDH3a overexpression.expressions of PGC1a and TFB1M, two proteins that are master
regulators of mitochondrial biogenesis and gene expression,
were not altered (Figure 6A).CeWe next determined whether IDH3a regulates NDUFA4L2, us-
ing quantitative PCR and western blots, in fibroblasts with IDH3a
knockdown or YC-1 treatment. Both quantitative PCR andll Reports 10, 1335–1348, March 3, 2015 ª2015 The Authors 1343
western blot analyses showed that, under normoxic conditions,
IDH3a knockdown increased, whereas YC-1 inhibited NDU-
FA4L2 expression (Figure 6B). In addition, YC-1 treatment
blocked NDUFA4L2 upregulation mediated by IDH3a knock-
down. These data suggest that HIF-1a is responsible for ID-
H3a-regulated NDUFA4L2 expression. Consistent with this
idea, IDH3a overexpression decreased the expression of NDU-
FA4L2 (Figure 6B, right). The effect of miR-424 on NDUFA4L2
expression also was determined. Both quantitative PCR and
western blot analyses revealed that, under normoxic conditions,
miR-424 overexpression increased NDUFA4L2 expression while
YC-1 inhibited this increase (Figure 6C). These data indicate that
IDH3a regulates NDUFA4L2 expression through HIF-1a and that
NDUFA4L2 is responsible for reduced oxidative phosphorylation
mediated by IDH3a downregulation.
To further confirm that IDH3a regulates oxidative phosphory-
lation through NDUFA4L2, oxygen consumption was analyzed
in fibroblasts with knockdown of either IDH3a and/or NDU-
FA4L2. NDUFA4L2 knockdown alone increased the basal oxy-
gen consumption under normoxic conditions, whereas IDH3a
knockdown alone decreased the basal oxygen consumption;
NDUFA4L2 knockdown partially rescued (70%) the repressed
oxygen consumption mediated by IDH3a knockdown (Fig-
ure 6D). Moreover, IDH3a knockdown inhibited oxidative phos-
phorylation and reduced oxygen consumption under normoxia.
NDUFA4L2 knockdown rescued the decrease of oxidative phos-
phorylation mediated by IDH3a knockdown in comparison with
control fibroblasts (Figure 6D). Taken together, these data
demonstrate that IDH3a regulates the expression of NDUFA4L2,
which in turn modulates oxidative phosphorylation and oxygen
consumption.
IDH3a Downregulation Is Responsible for the Tumor-
Promoting Effects of CAFs
To investigate whether the IDH3a downregulation is responsible
for the tumor-promoting effects of CAFs in vivo, we established
fibroblasts with IDH3a knockdown or overexpression. A375
melanoma cells or HCT116 colon cancer cells were mixed with
control or IDH3a-silenced fibroblasts, and injected into the
abdominal or forelimb armpits of nudemice (sixmice/group) (Fig-
ures 7A and S4). While both control fibroblasts and fibroblasts
with IDH3a knockdown did not grow into tumors, A375 cells
that contained fibroblasts with IDH3a knockdown grew much
faster and produced bigger tumors than those with control fibro-
blasts. Similarly, A375 cells that contained TGF-b-induced CAFs
grew bigger tumors than those with control fibroblasts (Fig-
ure 7B); however, overexpression of IDH3a in CAFs significantly
abolished the growth-promoting effect of CAFs. Furthermore,
A375 cells that contained fibroblasts with miR-424 overexpres-
sion also grew faster than those with control fibroblasts (Fig-
ure 7C). Taken together, our data demonstrate that the reduction
of IDH3a contributes to the tumor-promoting effects of CAF.
DISCUSSION
Previous studies have demonstrated that glycolytic enzymes,
such as LDH and PKM2, and products such as lactate are upre-
gulated in breast cancer CAFs under normoxic conditions. How-1344 Cell Reports 10, 1335–1348, March 3, 2015 ª2015 The Authorsever, it is not clear whether aerobic glycolysis is a general meta-
bolic feature of CAFs, and, if so, what regulates this aerobic
glycolysis. In this study, we examined and compared lactate pro-
duction, glucose uptake, and oxygen consumption in fibroblasts
and CAFs. In two induced-CAF models (TGF-b induced and
PDGF induced) and isolated CAFs from human colon cancer
and melanoma, lactate production and glucose uptake were in-
creased, whereas oxygen consumption was decreased, clearly
demonstrating that aerobic glycolysis was increased in both
the induced CAFs and the isolated CAFs. Our data suggest
that aerobic glycolysis is a common feature of CAFs. Moreover,
CAV1, a potential marker of CAFs in human breast cancers and
associated with tumor recurrence, metastasis, and poor clinical
outcome (Bonuccelli et al., 2010a; Sotgia et al., 2009), was
downregulated in CAFs, whether induced or isolated, suggesting
that CAV1 downregulation is a consequence rather than a cause
of CAF formation.
The mechanism of an oxygen-independent metabolic switch
from oxidative phosphorylation to aerobic glycolysis in CAFs
is not well defined. Here we report that IDH3a downregulation
triggers the metabolic switch from oxidative phosphorylation to
glycolysis. CAFs isolated from colon cancers and melanomas
are glycolytic. In vitro TGF-b- or PDGF-induced CAFs promote
a switch from oxidative phosphorylation to aerobic glycolysis.
IDH3a is a critical rate-limiting enzyme in the TCA cycle and
commonly decreased in CAFs. Although IDH1 also was downre-
gulated in CAF, our functional studies revealed that knockdown
of IDH3a, but not IDH1or IDH2, increasedglycolysis and inhibited
oxidative phosphorylation in fibroblasts. Moreover, overexpres-
sion of IDH3a prevented fibroblasts from transforming into CAFs.
Hypoxia has been implicated in the metabolic reprogramming
of cancer cells, and HIF-1a plays an important role in the regula-
tion of glycolysis (Denko, 2008; Fiaschi et al., 2012; Mimura et al.,
2012; Sonveaux et al., 2008). Our data demonstrate that HIF-1a,
but not HIF-2a or HIF-3a, is increased in CAFs both in vitro
and in vivo, and that downregulation of IDH3a results in HIF-1a
protein stabilization. HIF-1a stability is regulated by ubiquitin-
dependent proteasome degradation. Ubiquitination of HIF-1a
is triggered by hydroxylation at the P402 and/or P564 of HIF-
1a. PHD2 was found to directly regulate HIF-1a hydroxylation
(Lee et al., 2008; Minervini et al., 2013; Tennant et al., 2009).
PHD2 activity is activated by oxygen and a-KG but suppressed
by fumurate and succinate, two inhibitory metabolic structural
analogs of a-KG. Our results showed that IDH3a downregulation
decreased the level of effective a-KG by reducing the ratio of
a-KG to fumurate and succinate, resulting in PHD2 inhibition
and HIF-1a stabilization in CAFs.
Downregulation of IDH3a increases the protein level of HIF-1a.
The accumulation of HIF-1a, in turn, promotes glycolysis, by
upregulating the uptake of glucose and expression of glycolytic
enzymes under normoxic conditions, and inhibits oxidative
phosphorylation by upregulating NDUFA4L2, the negative regu-
lator of complex I. Although the IDH3a-HIF-1a-signaling axis
regulates NDUFA4L2 expression under normoxic conditions,
we have not excluded the possibility that NDUFA4L2 is regulated
by other transcription factors. This is because IDH3a downregu-
lation reduces the effective level of a-KG, which suppresses the
activity of other dioxygenases, such as the Jumonji family of
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Figure 7. IDH3a Knockdown Contributes to
Tumor-Promoting Effects of CAFs
(A) IDH3a knockdown enhances tumor growth-
promoting effect of CAF. (Left) Injection sites in
xenograft mouse model. (Middle) Tumor growth of
A375 cells co-injected with control or fibroblasts
depleted of IDH3a (*p < 0.01). (Right) Represen-
tative tumors. Corresponding positions in pictures
indicate tumors taken from the same mouse.
(B) IDH3a overexpression impairs tumor growth-
promoting effect of CAF. (Left) Injection sites in
xenograft mouse model. (Middle) Tumor growth of
A375 cells co-injected with control or fibroblasts
overexpressing IDH3a (*p < 0.01). (Right) Repre-
sentative tumors.
(C) miR-424 overexpression enhances tumor
growth-promoting effect of CAF. (Left) Injection
sites in xenograft mouse model. (Middle) Tumor
growth of A375 cells co-injected with control or
fibroblasts overexpressing miR-424 (*p < 0.01).
(Right) Representative tumors.
(D) Our model: miR-424-mediated downregulation
of IDH3a promotes aerobic glycolysis through an
increase in HIF-1a stability in CAFs.histone demethylases. IDH3a can regulate NDUFA4L2 expres-
sion through these histone demethylases in CAFs, an interesting
possibility that should be explored in the future.
Although tumor cells also are known to be addicted to glycol-
ysis, our study suggests that the roles of glycolysis in tumor cells
and CAFs are different. The major function of glycolysis in tumor
cells is to produce building blocks for biosynthesis and to main-
tain ATP production under hypoxia. Our results indicate that
CAFs also are prone to glycolysis and that the increased glyco-
lytic traits in CAFs are responsible for the tumor-promoting effect
of CAFs. Because the proliferation of CAFs decreases, rather
than increases, compared to primary fibroblasts, it seems likely
that the increased glycolysis in CAFs is not for the proliferationCell Reports 10, 1335–134and growth of CAFs, but for the rapid
proliferation of tumor cells by providing
the required building blocks and support-
ing niche. Our results further identified
IDH3a as a molecular switch promoting
aerobic glycolysis (Figure 7D), and pro-
vided insights into the initiation of the
Warburg-like effect in CAFs. Our study in-
dicates that the increased glycolytic traits
in CAFs are responsible for the tumor-
promoting effect of CAFs. Targeting the
glycolytic events in both tumor cells and
their nearby CAFs may represent a novel
and effective approach for inhibiting tu-
mor development and progression.
EXPERIMENTAL PROCEDURES
Cells and Reagents
A375 melanoma cells (ATCC) were cultured in
DMEM with 10% fetal bovine serum (FBS).
Glucose-deprived DMEM was purchased fromGibco. Human recombinant TGF-b1 was purchased from Peprotech. SYBR
Green PCR master mix and the TaqMan microRNA reverse transcription kit
were purchased from ABI. The lactate and cell proliferation assay kits were
purchased from BioVision Technologies and Roche, respectively. Monoclonal
antibodies against IDH3a, b-actin, andGAPDHwere purchased fromOriGene.
The 20-O-methyl chemically modified single-stranded RNA designed to inhibit
the endogenous mature miR-424, and negative control miRNA were pur-
chased from GenePharma.
Clinical Samples
Tissue collection was approved by the Medical Ethical Committee of the
Shanghai Jiao Tong University School of Medicine. Foreskin tissues were
collected after informed consent from children aged 7 to 12 years at the affil-
iated Xinhua Children Hospital of the Shanghai Jiao Tong University School of
Medicine. Fresh and paraffin-embedded colon cancer blocks or peripheral8, March 3, 2015 ª2015 The Authors 1345
normal colon tissue were collected after informed consent from patients un-
dergoing surgery at the affiliated Ruijin Hospital of the Shanghai Jiao Tong Uni-
versity School of Medicine. Paraffin-embedded primary melanoma blocks or
normal skin tissue were collected after informed consent from patients under-
going surgery at the affiliated Renji Hospital of the Shanghai Jiao Tong Univer-
sity School of Medicine.
Isolation of Human Normal Primary Fibroblasts and CAFs
Human normal primary fibroblasts and CAFs were isolated from foreskin or
from colon cancer tissues, respectively. After posthectomy, the foreskins
were immediately transported to the laboratory on ice. The foreskins were
minced and then digested with 0.1% type I collagenase and trypsin. After
digestion, the tissue was filtered with a 400-mesh sieve, and the filtrate was
centrifuged at 1,000 3 g for 10 min. Cells obtained from the pellet were
cultured with DMEM containing 10% FBS for 2 hr; the attached cells, verified
by F-actin staining (Figure 1), were fibroblasts. After three passages, the cells
were frozen in liquid nitrogen for further experiments.
Luciferase Assay
For the 30-UTR luciferease assay, the full-length 30 UTR of the human IDH3a
gene (1129–2655 nt, GenBank accession number NM_005530.2) was ampli-
fied using a human cDNA library as a template. To generate a mutant IDH3a
30 UTR, site-directed mutagenesis was performed. The primers for mutagen-
esis were sense, 5- CTTTGTTTAAGCAGGTCCATCCTCTGTTT-3, and anti-
sense, 5-AACAGAGGATGGACCTGCTTAAACAAAG-3. In the mutant 30
UTR, the nucleotide sequence that is complementary to the seed region of
miR-424 was replaced with the sequence shown in Figure 4B (CTGCTGCTT
to CAGGTCCAT). The 293T cells were co-transfected with 50 ng pGL3-
IDH3a 30 UTR (wild-type or mutant) and 500 ng miR-424 overexpression
plasmid. The empty vector was used as a control, and the renilla plasmid
pRL-TK was used as an internal control. Cells were harvested 48 hr after
transfection and analyzed with the Dual-Luciferase Reporter Assay kit. Firefly
luciferase values were normalized to renilla luciferase values from the same
cells. The assays were repeated at least three times in independent
experiments.
For the ODD luciferase assay, the ODD domain of HIF-1a (GenBank acces-
sion number U59496) was fused to the 50 end of the firefly luciferase reporter
gene (Dewhirst et al., 2007). As a control, a luciferase expression vector in
which the luciferase gene is driven by the CMV promoter was used.
Quantitative Real-Time PCR
Total cellular RNA was extracted using the guanidinium isothiocyanate and
phenol-chloroform method. For the quantification of mRNA, 1 mg total RNA
was reverse transcribed into cDNA with MMLV reverse transcriptase accord-
ing to the manufacturer’s instructions. Quantitative real-time PCR reactions
were performed in triplicate in a 96-well plate using 1 ml cDNA. The b-actin
gene was used as an internal control for normalization. For the quantification
of miRNA, the TaqMan microRNA reverse transcription kit was used with the
stem loop primer according to the manufacturer’s instructions, and the results
were normalized to RNU48.
Oligo- or Lentivirus-Mediated shRNA Knockdown and Lentivirus-
Mediated Gene Overexpression
A quantity of 50 nM oligomer (inhibitor) targeting miR-424 was transfected
using RNAi Max (Invitrogen) according to the manufacturer’s directions.
Primary human fibroblasts were seeded in 60-mm dishes at 30% conflu-
ence. After 48 hr, the cells were analyzed or further treated with 8 ng/ml
TGF-b1.
Specific shRNA sequences targeting IDH3a were inserted into the pGIPZ
lentiviral vector (Open Biosystems); the IDH3a coding sequence was cloned
into the pHR-SIN lentiviral vector. These lentiviral plasmids were co-trans-
fected into 293T cells with psPAX2 and pMD2G to generate the lentiviruses
using Lipofectamine 2000 (Invitrogen). Viral stocks were collected from the
transduced 293T cells 72 hr post-transfection, and were used to infect human
fibroblasts with 6 mg/ml polybrene. Lentivirus-mediated miR-424 knockdown
was performed with the pPACKH1 lentivector packaging system (System Bio-
sciences), according to the manufacturer’s instructions.1346 Cell Reports 10, 1335–1348, March 3, 2015 ª2015 The AuthorsImmune Staining
Immunofluorescence staining was performed on cultured cells. After fixation
and permeabilization, the cells were incubated with primary antibodies at
4C overnight, followed by the appropriate Alexa Fluor 488-conjuated second-
ary antibodies. The cells were visualized by fluorescence microscopy.
Immunohistochemical staining was used for paraffin-embedded clinical
samples. After deparaffinization and rehydration, the tissue sections were
incubated with antibodies overnight at 4C, followed by incubation with perox-
idase-labeled anti-chicken antibodies. Finally, antibody binding was visualized
with a DAB substrate (ImmunoPure).
Cell Proliferation Assay
Human fibroblasts were cultured in media containing D-glucose or galactose
(4,500 mg/l) for 24 hr, after which the supernatants were collected. A375 mel-
anoma cells were co-cultured with this supernatant. After incubation for the
indicated times, BrdU cooperation assays (Roche) were performed. The
absorbance at 370 nm was measured using a microplate reader.
Aerobic Glycolysis Analysis
Extracellular lactate was measured with a lactate assay kit (BioVision Technol-
ogies). Briefly, 5 3 105 fibroblasts were seeded in 60-mm dishes overnight.
The cells were incubated in DMEM without FBS prior to assay, the superna-
tants were collected at the indicated time points (1, 2, or 3 hr), and lactate
levels were quantified by the colorimetric assay, according to the manufac-
turer’s instructions.
The glucose uptake rate was determined as previously described (Yama-
moto et al., 2011). Cells were incubated in the media containing 12 mM
glucose for 24 hr. After three washes with KRP buffer, the cells were incubated
for 30 min in KRP buffer and then incubated in KRP containing 0.5 mCi/ml [3H]-
deoxyglucose (PerkinElmer) for 10min. After washing, the cells were lysedwith
1 ml 0.1 N NaOH and incubated at 37C for 2 hr. An aliquot of 0.5 ml was used
for scintillation counting.
The oxygen consumption rate (OCR) was measured using a Seahorse XF24
technology (Seahorse Bioscience). Briefly, 2.53 104 cells were seeded on the
special plate for 24 hr. The OCRwas measured under basal conditions and af-
ter the addition of oligomycin (1 mM), FCCP (1 mM), and rotenone (1 mM)/anti-
mycin (1 mM).
Cellular Succinate, Fumurate, and a-KG Detection
The cellular content of succinate, fumurate, and a-KG were analyzed by
GC-MS as previously described (Chan et al., 2009). The cells (1 3 108)
were harvested and suspended in chloroform-methanol-water (2:1:1, v/
v/v). The derivatized sample was injected into a Shimadzu QP 2010 GC tan-
dem quadrupole mass spectrometer. The GC separation was performed on
an Agilent DB-5 mass spectrometer fused silica capillary column (30 m 3
0.25 mm 3 0.25 mm). The column temperature was 70C for the first
3 min and then increased at 5C/min to 310C for 5 min. The injection tem-
perature was set as 300C, and the injection volume was 1 ml with a 10:1
split ratio. Helium (99.9995%) was applied as a carrier gas. The column
flow was 1.2 ml/min, and the column was equipped with a linear velocity
control. The mass spectra scanning scope was set to 33600 m/z in the
full-scan mode with a scan speed of five scans s1 and a solvent cut
time of 5.6 min based on the retention time of the pyridine solvent. The tem-
peratures of the interface and the ion source were adjusted to 280C and
240C, respectively. The detector voltage was maintained at 1.2 kV, and
the electron impact (EI) model was selected to achieve ionization of the me-
tabolites at 70 eV.
Mice Tumor Xenografts
Four-week-old BALB/c nude mice were obtained from a Shanghai animal
laboratory. The animals were handled according to the protocol approved
by the Institutional Animal Care and Use Committee of the Shanghai Jiao
Tong University School of Medicine. Tumor xenografts were generated by
subcutaneously co-injecting human fibroblasts with A375 cells (the ratio of
fibroblasts to A375 cells was 3:1, and the total cell number in each injection
was 4 3 106) into the armpits bilaterally. The tumor volume was determined
weekly using digital caliper measurements and the following formula: tumor
volume (mm3) =½3 longest diameter23 shortest diameter. After 5 weeks, the
mice were sacrificed and the tumors were excised.
Statistical Analysis
The animal data are presented as the medians ± SD, whereas other data are
presented as the means ± SD. All data are representative of at least three in-
dependent experiments. The differences between groups were assessed by
Student’s t test; all reported differences are p < 0.05 unless otherwise stated.
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